TRUS - Transrectal Ultrasound Procedure

Transrectal ultrasound procedures, which is performed with the patient positioned either lying on his side or reclining and with his knees bent, involves using a small cylinder-shaped transducer, which is lubricated and inserted into the rectum, and a monitoring device. The transducer directs high-frequency sound waves into the body. As these sound waves are reflected back to the transducer, it records and transmits them to the monitoring device, which creates the images (sonograms).

In the presence of an abnormal PSA and/or if the results of TRUS are suspicious for prostate cancer, a prostate biopsy is performed. During biopsy, transrectal ultrasound is used to help the physician properly place the needle, which is projected through the tip of a probe inserted through the rectum to the prostate. The biopsy needle is used to extract a tissue sample from one or more areas of the prostate. The biopsy samples are sent to a pathologist (physician who identifies diseases by studying cells under a microscope) who analyzes the sample(s) for the presence of prostate cancer.

Envisioneering Medical focuses resources and technology to develop equipment to aid physicians in detection, diagnosis and treatment. The TargetScan 3D imaging and targeted biopsy system offers the first real advance in prostate imaging and biopsy in over a decade. It eases any discomfort of probing during examination, as once it is place, there is no need for repositioning. The system allows a physician to generate a true solid 3D image, manipulate it, and precisely plan and undertake a multi-sample biopsy of a targeted tissue mass in the prostate. Click to learn more about TargetScan 3D or ask your physician today.